biotech news

[#item_full_content] … [Read more...] about Faron Reports Half-Year Financial Results, January 1 – June 30, 2023

[#item_full_content] … [Read more...] about Faron Receives FDA Orphan Drug Designation for Bexmarilimab in Acute Myeloid Leukemia

[#item_full_content] … [Read more...] about CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

[#item_full_content] … [Read more...] about Pliant Therapeutics Announces Three Upcoming Presentations at the European Respiratory Society International Congress 2023

[#item_full_content] … [Read more...] about LianBio Announces Results from Phase 3 EXPLORER-CN Trial of Mavacamten Presented at the European Society of Cardiology Congress and Simultaneous Publication in JAMA Cardiology

[#item_full_content] … [Read more...] about 联拓生物宣布Mavacamten （玛伐凯泰）的EXPLORER-CN III期临床研究结果在欧洲心脏病学会年会上公布并同步发表于《JAMA Cardiology》

[#item_full_content] … [Read more...] about Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus  

[#item_full_content] … [Read more...] about Galapagos kondigt de start aan van een fase 2-studie met de selectieve TYK2-remmer GLPG3667 bij patiënten met actieve systemische lupus erythematodes  

[#item_full_content] … [Read more...] about Genmab to Present at Morgan Stanley 21st Annual Global Healthcare Conference

[#item_full_content] … [Read more...] about T2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs